ASX ANNOUNCEMENT 30 October 2026 Quarterly Activities Report and Appendix 4C Bio-Gene Technology Limited (ASX:BGT, “Bio-Gene” or “the Company”), an Australian agtech company developing the next generation of novel insecticides derived from nature, provides an update on activities for the...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Bio-Gene Technology Ltd. on 6ix
Earlier from Bio-Gene Technology
- Appendix 4E and 2026 Annual Report
- Results of Placement
- Sumitomo & Nakashima to launch Qcide products in Japan
- Regulatory Development of Flavocide
- Appendix 4D and Half-Year Accounts 31 December 2025
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology